EP1850874
Lenging á tíma til sjúkdómsframvindu eða lifun hjá sjúklingum með eggjastokkakrabbamein með því að nota pertúsúmab
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
21.2.2006EP published:
16.10.2013EP application number:
06735838.2
EP translation filed:
4.12.2013Grant published:
15.12.2013EPO information:
European Patent Register
Max expiry date:
20.2.2026Expiry date:
20.2.2017
Title:
EXTENDING TIME TO DISEASE PROGRESSION OR SURVIVAL IN OVARIAN CANCER PATIENTS USING PERTUZUMAB
Timeline
Today
21.2.2006EP application
16.10.2013EP Publication
4.12.2013Translation submitted
15.12.2013Registration published
20.2.2017Expires
Owner
Name:
Genentech, Inc.Address:
1 DNA Way, 94080-4990, South San Francisco, CA, US
Inventor
Name:
DERYNCK, Mika K.Address:
San Mateo, California, US
Name:
KELSEY, Stephen M.Address:
Montara, California, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
655277 PDate:
23.2.2005Country:
US
Classification
Categories:
A61K 39/395, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 21.1.2014
Expires: 20.2.2015
Payer: Örn Þór, slf.
Number: 10
Paid: 16.1.2015
Expires: 20.2.2016
Payer: Örn Þór, slf.
Number: 11
Paid: 12.1.2016
Expires: 20.2.2017
Payer: Örn Þór, slf.